Zacks Investment Research noted EndoChoice has been assigned a consensus broker rating score of 1.00 — strong buy — from the four brokers that provide coverage for the company.
Following CMS’ decision to maintain Medicare reimbursement for Cologuard, Exact Sciences’ shares rose 6.8 percent, according to a Journal Sentinel report.
Modernizing Medicine completed the previously announced acquisition of gMed.
The American Gastroenterological Association, Crohn’s & Colitis Foundation of America and Janssen Biotech selected Theresa Alenghat, VMD, PhD as the inaugural winner of the 2015 AGA-CCFA-Janssen Research Award in Inflammatory Bowel Disease Epigenetics Research.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
Kentucky to receive $2.6M for improving CRC screenings, outcomes: 4 key notes
To stay or go? When GI physicians consider changing practice settings
CMS votes to uphold Medicare reimbursement for Cologuard
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
